• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ISL2 是一种假定的肿瘤抑制因子,其表观遗传沉默重编程了胰腺癌的代谢。

ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer.

机构信息

Northwestern University Feinberg School of Medicine, Robert Lurie Comprehensive Cancer Center, Department of Obstetrics and Gynecology, Chicago, IL 60611, USA.

Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA 22903, USA.

出版信息

Dev Cell. 2022 Jun 6;57(11):1331-1346.e9. doi: 10.1016/j.devcel.2022.04.014. Epub 2022 May 3.

DOI:10.1016/j.devcel.2022.04.014
PMID:35508175
Abstract

Pancreatic ductal adenocarcinoma (PDA) cells reprogram their transcriptional and metabolic programs to survive the nutrient-poor tumor microenvironment. Through in vivo CRISPR screening, we discovered islet-2 (ISL2) as a candidate tumor suppressor that modulates aggressive PDA growth. Notably, ISL2, a nuclear and chromatin-associated transcription factor, is epigenetically silenced in PDA tumors and high promoter DNA methylation or its reduced expression correlates with poor patient survival. The exogenous ISL2 expression or CRISPR-mediated upregulation of the endogenous loci reduces cell proliferation. Mechanistically, ISL2 regulates the expression of metabolic genes, and its depletion increases oxidative phosphorylation (OXPHOS). As such, ISL2-depleted human PDA cells are sensitive to the inhibitors of mitochondrial complex I in vitro and in vivo. Spatial transcriptomic analysis shows heterogeneous intratumoral ISL2 expression, which correlates with the expression of critical metabolic genes. These findings nominate ISL2 as a putative tumor suppressor whose inactivation leads to increased mitochondrial metabolism that may be exploitable therapeutically.

摘要

胰腺导管腺癌(PDA)细胞重新编程其转录和代谢程序,以在营养贫乏的肿瘤微环境中存活。通过体内 CRISPR 筛选,我们发现胰岛 2 (ISL2)是一种候选肿瘤抑制因子,可调节侵袭性 PDA 的生长。值得注意的是,ISL2 是一种核和染色质相关的转录因子,在 PDA 肿瘤中被表观遗传沉默,高启动子 DNA 甲基化或其表达降低与患者预后不良相关。外源性 ISL2 表达或 CRISPR 介导的内源性基因座上调可降低细胞增殖。在机制上,ISL2 调节代谢基因的表达,其缺失会增加氧化磷酸化(OXPHOS)。因此,ISL2 耗尽的人 PDA 细胞对体外和体内线粒体复合物 I 的抑制剂敏感。空间转录组学分析显示肿瘤内异质性的 ISL2 表达,与关键代谢基因的表达相关。这些发现将 ISL2 作为一种潜在的肿瘤抑制因子,其失活会导致线粒体代谢增加,这可能具有治疗潜力。

相似文献

1
ISL2 is a putative tumor suppressor whose epigenetic silencing reprograms the metabolism of pancreatic cancer.ISL2 是一种假定的肿瘤抑制因子,其表观遗传沉默重编程了胰腺癌的代谢。
Dev Cell. 2022 Jun 6;57(11):1331-1346.e9. doi: 10.1016/j.devcel.2022.04.014. Epub 2022 May 3.
2
ISL2 modulates angiogenesis through transcriptional regulation of ANGPT2 to promote cell proliferation and malignant transformation in oligodendroglioma.ISL2 通过转录调控 ANGPT2 调节血管生成,促进少突胶质细胞瘤中的细胞增殖和恶性转化。
Oncogene. 2020 Sep;39(37):5964-5978. doi: 10.1038/s41388-020-01411-y. Epub 2020 Aug 4.
3
The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.U2AF2/circRNA ARF1/miR-342-3p/ISL2 反馈环调节神经胶质瘤干细胞中的血管生成。
J Exp Clin Cancer Res. 2020 Sep 7;39(1):182. doi: 10.1186/s13046-020-01691-y.
4
Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer.LIM同源盒6(LHX6)基因的甲基化介导沉默促进人胰腺癌中的细胞增殖。
Biochem Biophys Res Commun. 2020 Jun 4;526(3):626-632. doi: 10.1016/j.bbrc.2020.03.120. Epub 2020 Apr 2.
5
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinoma.异质性胰腺导管腺癌中的代谢可塑性
Biochim Biophys Acta. 2016 Dec;1866(2):177-188. doi: 10.1016/j.bbcan.2016.09.001. Epub 2016 Sep 4.
6
Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer.表观遗传和转录控制的表皮生长因子受体调节胰腺癌的肿瘤免疫微环境。
Cancer Discov. 2021 Mar;11(3):736-753. doi: 10.1158/2159-8290.CD-20-0519. Epub 2020 Nov 6.
7
Adaptation of pancreatic cancer cells to nutrient deprivation is reversible and requires glutamine synthetase stabilization by mTORC1.胰腺癌细胞对营养缺乏的适应是可逆的,需要 mTORC1 稳定谷氨酰胺合成酶。
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10). doi: 10.1073/pnas.2003014118.
8
LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.LHX6 作为一种新型潜在的抑癌基因,在肺癌中通过表观遗传失活发挥作用。
Cell Death Dis. 2013 Oct 24;4(10):e882. doi: 10.1038/cddis.2013.366.
9
Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.自噬-溶酶体功能的转录调控驱动胰腺癌代谢。
Nature. 2015 Aug 20;524(7565):361-5. doi: 10.1038/nature14587. Epub 2015 Jul 13.
10
Functional Genomics Identifies Metabolic Vulnerabilities in Pancreatic Cancer.功能基因组学鉴定胰腺癌的代谢脆弱性。
Cell Metab. 2021 Jan 5;33(1):199-210.e8. doi: 10.1016/j.cmet.2020.10.018. Epub 2020 Nov 4.

引用本文的文献

1
Epigenetic Changes Associated With Obesity-related Metabolic Comorbidities.与肥胖相关代谢合并症相关的表观遗传变化
J Endocr Soc. 2025 Aug 4;9(9):bvaf129. doi: 10.1210/jendso/bvaf129. eCollection 2025 Sep.
2
CRISPR/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook.CRISPR/Cas技术在胰腺癌研究与治疗中的应用:最新进展与未来展望
Discov Oncol. 2025 Aug 11;16(1):1530. doi: 10.1007/s12672-025-03383-5.
3
Plasma DNA Methylation-Based Biomarkers for MPNST Detection in Patients With Neurofibromatosis Type 1.
基于血浆DNA甲基化的生物标志物用于1型神经纤维瘤病患者MPNST的检测
Mol Carcinog. 2025 Jan;64(1):44-56. doi: 10.1002/mc.23825. Epub 2024 Nov 26.
4
Emerging mechanisms and promising approaches in pancreatic cancer metabolism.胰腺癌代谢中的新兴机制与前景广阔的方法
Cell Death Dis. 2024 Aug 1;15(8):553. doi: 10.1038/s41419-024-06930-0.
5
Identification of prognostic indicators, diagnostic markers, and possible therapeutic targets among LIM homeobox transcription factors in breast cancer.乳腺癌中LIM同源框转录因子的预后指标、诊断标志物及潜在治疗靶点的鉴定
Cancer Innov. 2022 Sep 26;1(3):252-269. doi: 10.1002/cai2.30. eCollection 2022 Oct.
6
A prognostic estimation model based on mRNA-sequence data for patients with oligodendroglioma.一种基于少突胶质细胞瘤患者mRNA序列数据的预后评估模型。
Front Neurol. 2022 Dec 14;13:1074593. doi: 10.3389/fneur.2022.1074593. eCollection 2022.
7
Epigenetics in Pancreatic Ductal Adenocarcinoma: Impact on Biology and Utilization in Diagnostics and Treatment.胰腺导管腺癌中的表观遗传学:对生物学的影响及其在诊断和治疗中的应用
Cancers (Basel). 2022 Nov 30;14(23):5926. doi: 10.3390/cancers14235926.
8
Ten Years of CRISPRing Cancers In Vitro.CRISPR技术在体外研究癌症的十年
Cancers (Basel). 2022 Nov 23;14(23):5746. doi: 10.3390/cancers14235746.
9
The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma.肿瘤内异质性在胰腺导管腺癌生物学和治疗中的作用。
Oncogene. 2022 Oct;41(42):4686-4695. doi: 10.1038/s41388-022-02448-x. Epub 2022 Sep 10.